ZERBINI, MARIALUISA
 Distribuzione geografica
Continente #
NA - Nord America 6.424
AS - Asia 5.750
EU - Europa 4.886
AF - Africa 314
Continente sconosciuto - Info sul continente non disponibili 291
SA - Sud America 231
OC - Oceania 5
Totale 17.901
Nazione #
US - Stati Uniti d'America 6.343
CN - Cina 1.742
SG - Singapore 1.439
VN - Vietnam 1.434
GB - Regno Unito 1.304
IT - Italia 639
DE - Germania 625
UA - Ucraina 582
SE - Svezia 528
HK - Hong Kong 369
FR - Francia 316
IN - India 316
RU - Federazione Russa 281
IE - Irlanda 176
BR - Brasile 167
JP - Giappone 123
ZA - Sudafrica 101
KR - Corea 100
CH - Svizzera 89
EE - Estonia 84
TG - Togo 72
NL - Olanda 53
SC - Seychelles 50
CA - Canada 47
FI - Finlandia 47
CI - Costa d'Avorio 45
BG - Bulgaria 42
BE - Belgio 35
IR - Iran 32
BD - Bangladesh 31
NG - Nigeria 28
AR - Argentina 25
GR - Grecia 20
IQ - Iraq 19
PH - Filippine 17
AT - Austria 16
TH - Thailandia 15
UZ - Uzbekistan 15
ID - Indonesia 13
RO - Romania 12
EC - Ecuador 11
JO - Giordania 11
PK - Pakistan 11
PL - Polonia 11
TW - Taiwan 11
SA - Arabia Saudita 10
TR - Turchia 9
MX - Messico 8
CO - Colombia 7
LB - Libano 7
ES - Italia 6
HN - Honduras 6
MY - Malesia 6
PY - Paraguay 6
CL - Cile 5
EG - Egitto 5
AU - Australia 4
AZ - Azerbaigian 4
JM - Giamaica 4
PE - Perù 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
LT - Lituania 3
OM - Oman 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BM - Bermuda 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
PS - Palestinian Territory 2
TN - Tunisia 2
VE - Venezuela 2
BB - Barbados 1
BO - Bolivia 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
KE - Kenya 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
SV - El Salvador 1
TZ - Tanzania 1
Totale 17.612
Città #
Southend 1.100
Singapore 916
Ashburn 614
Chandler 540
Fairfield 458
Dong Ket 448
Jacksonville 404
San Jose 354
Hong Kong 351
Hefei 291
Ho Chi Minh City 244
Wilmington 244
Ann Arbor 243
Seattle 242
Princeton 239
Woodbridge 232
Houston 224
Hanoi 196
Beijing 192
Council Bluffs 189
Boardman 187
Dublin 171
Cambridge 156
Santa Clara 119
Tokyo 119
Padova 115
Westminster 115
Nanjing 110
Lauterbourg 104
Los Angeles 91
Berlin 85
Seoul 82
Milan 80
New York 80
Bern 78
Buffalo 74
Medford 73
Lomé 72
Mülheim 69
Saint Petersburg 63
Shenyang 58
Jinan 52
Mahé 47
Abidjan 45
Helsinki 44
Shanghai 44
Sofia 42
Tianjin 42
Changsha 41
Bologna 40
Bengaluru 38
Dallas 38
Guangzhou 37
Redwood City 37
Haiphong 36
Nanchang 36
Brussels 35
Hebei 31
Zhengzhou 31
Florence 28
Abeokuta 27
Da Nang 26
Hangzhou 25
San Diego 25
Verona 25
Bremen 24
Des Moines 23
Frankfurt am Main 22
Jiaxing 22
Phoenix 20
Toronto 20
Paris 19
San Francisco 19
Olalla 18
Taizhou 18
Rome 17
San Venanzo 17
Chicago 16
Norwalk 16
Shijiazhuang 15
São Paulo 15
London 14
Ningbo 14
Wuhan 14
Shenzhen 13
Taiyuan 13
The Dalles 13
Turin 13
Yubileyny 13
Haikou 12
Redondo Beach 12
Amman 11
Biên Hòa 11
Falkenstein 11
Falls Church 11
Kuban 11
Pune 11
Rio de Janeiro 11
Brooklyn 10
Curitiba 10
Totale 11.223
Nome #
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 254
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 245
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 230
Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting 217
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 213
Parvovirus in gravidanza: possibili conseguenze della trasmissione verticale 209
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 206
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 203
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 203
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 202
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 201
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 197
Analysis of HPV16 E6*I-II transcripts in cervical samples 195
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 194
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 193
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 193
A proteomic approach to the analysis of B19 capsid proteins 191
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 189
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 188
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 188
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 184
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 184
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 183
Analisi della competenza funzionale di cloni genomici di parvovirus B19 183
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 183
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 182
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 181
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 181
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 176
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 176
Recurrent erythema in patients with long-term parvovirus B19 infection 175
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 175
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C(HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy 174
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 170
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 168
Parvovirus B19-derived fetal complications following gestational infection. 168
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 167
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 166
Expression of bioactive recombinant bovine interferon-gamma using baculovirus 166
Analysis of the functional competence of genomic clones of Parvovirus B19 165
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 164
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 163
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 162
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 161
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 161
Lo studio PATER: Population-Based Frequency Assessment of HPV Infections in Borderline Pap Tests in the Emilia-Romagna Region 160
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 159
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 158
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 156
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 156
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 156
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 155
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 154
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 153
Diagnosi virologica di infezione da papillomavirus umani 152
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 152
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 152
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 152
Evidence of human bocavirus viremia in healthy blood donors. 152
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 151
Sviluppo di un saggio di spettrometria di massa, ad elevata processività, per la ricerca e genotipizzazione di 12 HPV ad alto rischio oncogeno 151
Parvovirus B19 in pregnancy: possible consequence of vertical transmission 150
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 150
Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study. 149
Factors predicting the outcome of conservately trated adenocarcinoma in situ of uterine cervix: an analysis of 166 cases 147
Human papillomavirus in melanoma: reply from authors 147
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 146
High-throughput type-specific detection of HPV using MassARRAY technology 144
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 144
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 143
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 143
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 143
Implicazioni nella progressione della patologia cervicale 141
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 139
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 135
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 135
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 135
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 134
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 134
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 133
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 131
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 131
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 131
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 130
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 129
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 128
La biologia molecolare nella diagnosi delle infezioni da HPV 127
B19 parvovirus infections: diagnostic technologies 127
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 127
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 127
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 126
Detection of parvovirus B19 IgG: choice of antigens and serological tests 123
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 117
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 115
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 115
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 115
Ricerca di HPV ad alto rischio oncogeno: Abbott Real Time HPV Assay e Digene HC2 HPV DNA Test a confronto 111
PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics 110
Investigation on the presence of B19 virus prototype and variant genotypes in a population of italian blood donors 107
Construction and functional analysis of B19 genomic clones 107
Totale 16.024
Categoria #
all - tutte 48.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.969


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.945 0 105 142 226 177 107 25 112 62 215 358 416
2022/20232.233 251 328 120 269 159 140 61 124 349 36 225 171
2023/2024807 38 96 40 131 47 161 114 70 19 34 17 40
2024/20251.975 73 333 211 134 278 104 221 52 17 61 52 439
2025/20264.650 337 594 495 420 581 298 333 128 833 338 163 130
2026/2027275 83 192 0 0 0 0 0 0 0 0 0 0
Totale 17.901